HomeXBIT • NASDAQ
add
XBiotech Inc
Previous close
$2.60
Day range
$2.50 - $2.68
Year range
$2.50 - $8.32
Market cap
76.22M USD
Avg Volume
45.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.55M | 24.85% |
Net income | -10.88M | -8.82% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -13.11M | -25.78% |
Effective tax rate | -0.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 155.90M | -22.45% |
Total assets | 181.86M | -20.19% |
Total liabilities | 7.15M | -61.51% |
Total equity | 174.71M | — |
Shares outstanding | 30.49M | — |
Price to book | 0.45 | — |
Return on assets | -17.78% | — |
Return on capital | -18.45% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.88M | -8.82% |
Cash from operations | -6.72M | 6.69% |
Cash from investing | -94.00K | 63.14% |
Cash from financing | -10.25M | -201.94% |
Net change in cash | -16.78M | -1,751.57% |
Free cash flow | -4.19M | 28.86% |
About
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Founded
2005
Headquarters
Website
Employees
90
